Tower Research Capital LLC (Trc) Lexaria Bioscience Corp. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,298 shares of LEXX stock, worth $1,259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,298
Previous 2,082
37.66%
Holding current value
$1,259
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding LEXX
# of Institutions
24Shares Held
1.28MCall Options Held
0Put Options Held
0-
Invenomic Capital Management LP Boston, MA550KShares$533,4480.05% of portfolio
-
Geode Capital Management, LLC Boston, MA172KShares$167,2830.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6130KShares$126,1240.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA128KShares$124,0340.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL61.3KShares$59,4120.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $5.77M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...